Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Drugs of the Future(1)
Frontiers in Oncology(1)
Journal of Clinical Oncology(1)
Pharmacoeconomics - Spanish Research Articles(1)
Área temáticas
Enfermedades(3)
Economía financiera(1)
Farmacología y terapéutica(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina y salud(1)
Área de conocimiento
Farmacología(1)
Origen
scopus(4)
Economic evaluation of nimotuzumab treatment for head and neck cancer in Cuba
ArticleAbstract: Objective: To evaluate the efficiency of nimotuzumab in the treatment of the patients diagnosed withPalabras claves:Autores:Carmen Elena Viada, Collazo Herrera M.M., Iznaga-Escobar N., Pérez Ruiz L.Fuentes:scopusNimotuzumab for Patients With Inoperable Cancer of the Head and Neck
ReviewAbstract: EGFR activation induces cell proliferation, neoformation of blood vessels, survival, and metastasisPalabras claves:eGFR, head and neck, Monoclonal antibody, nimotuzumab, RadiotherapyAutores:Iznaga-Escobar N., Mazorra Z., Mestre Fernández B., Tania CrombetFuentes:scopusUse of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients
ArticleAbstract: Purpose: To evaluate safety and preliminary efficacy of the humanized anti-epidermal growth factor rPalabras claves:Autores:Alvarez D., Cruz T., Del Castillo R., Fernández E., Figueredo R., Iznaga-Escobar N., Koropatnick J., Lage Davila A., Leonard I., Mon R., Osorio M., Pérez R., Ramos M., Renginfo E., Roca C., Tania Crombet, Torres O.Fuentes:scopush-R3: Treatment of Head and Neck Cancer Treatment of Epithelial Tumors Anti-EGFR MAb
ArticleAbstract: Epidermal growth factor receptor (EGFR) overexpression has been associated with alterations in cellPalabras claves:Autores:Iznaga-Escobar N., Parada A.C., Tania CrombetFuentes:scopus